Losardil 100/25 100 mg+25 mg (Tablet)
Unit Price: ৳ 12.05 (2 x 10: ৳ 241.00)
Strip Price: ৳ 120.50
Medicine Details
Category | Details |
---|---|
Generic | Losartan potassium hydrochlorothiazide |
Company | Drug international ltd |
Also available as |
Indications
- Treatment of hypertension
- Reduction of stroke risk in patients with hypertension and left ventricular hypertrophy
Pharmacology
- Potent vasoconstrictor
- Primary vasoactive hormone of the renin-angiotensin system
- Stimulates aldosterone secretion
- Selective blocking of angiotensin II
- Thiazide diuretic effect
- Increased excretion of Sodium and Chloride
- Reduction of plasma volume
- Increase in plasma renin activity
- Increase in Aldosterone secretion
- Increase in urinary Potassium loss
- Decrease in serum Potassium
- Mediated by angiotensin II
- Reversible, competitive inhibitor of the AT1 receptor
Dosage
- Usual starting dose of 50/12.5 is one tablet once daily
- Maximum dose of 100/25 once daily
- Initial dose for severe hypertension is one tablet of 50/12.5 once daily
- Initial treatment of severe hypertension is one tablet of 50/12.5 once daily
- No initial dosage adjustment of 50/12.5 is necessary for elderly patients
Administration
- May be administered with other antihypertensive agents
- May be administered with or without food
Interaction
- No significant drug-drug pharmacokinetic interactions found with Hydrochlorothiazide, Digoxin, Warfarin, Cimetidine, and Phenobarbital
- Potential interaction with potassium-sparing diuretics, potassium supplements, or salt substitutes containing potassium
- Possible interaction with non-steroidal anti-inflammatory drug Indomethacin
- Interaction with alcohol, barbiturates, or narcotics-potentiation of orthostatic hypotension may occur
- Dosage adjustment of the antidiabetic drug may be required with concurrent use
- Additive effect or potentiation with other antihypertensive drugs
- Impaired absorption in the presence of anionic exchange resins
Contraindications
- Hypersensitivity to any component of the product
- Anuria or hypersensitivity to other sulfonamide-derived drugs
Side Effects
- Symptomatic hypotension including dizziness
- Hyperkalaemia
- Angioedema
- Vertigo
- Gastro-intestinal disturbances
- Angina
- Palpitation
- Oedema
- Dyspnoea
- Headache
- Sleep disorders
- Malaise
- Urticaria
- Pruritus
- Rash
- Hepatitis
- Atrial fibrillation
- Cerebrovascular accident
- Syncope
- Pancreatitis
- Anaphylaxis
- Cough
- Depression
- Erectile dysfunction
- Anaemia
- Thrombocytopenia
- Hyponatraemia
- Arthralgia
- Myalgia
- Renal impairment
- Rhabdomyolysis
- Tinnitus
- Photosensitivity
- Vasculitis
Pregnancy & Lactation
- Avoided in pregnancy unless essential
- Adversely affect fetal and neonatal blood pressure control and renal function
- Skull defects and oligohydramnios reported
- Not recommended in breastfeeding
- Alternative treatment options available with better-established safety information during breastfeeding
Precautions & Warnings
- Hypersensitivity: Angiooedema
- Periodic determination of serum electrolytes
- Hypokalemia risk
- Impaired renal function
- Symptomatic hypotension
Use in Special Populations
- Use in Patients with Renal Impairment
- Use in Patients with Hepatic Impairment
- Use in pediatric patients
Overdose Effects
- Manifestations of overdosage including hypotension, tachycardia, and bradycardia
- Supportive treatment for symptomatic hypotension
- Potential electrolyte depletion and dehydration from excessive diuresis
- Possible accentuation of cardiac arrhythmias if digitalis has been administered
- Removal by hemodialysis not established
Therapeutic Class
- Combined antihypertensive preparations
Storage Conditions
- Do not store above 30°C
- Keep out of the reach of children
Related Brands
- Losart Plus 50 mg+12.5 mg (Tablet) - acme-laboratories-ltd
- Losart Plus 100 mg+12.5 mg (Tablet) - acme-laboratories-ltd
- Losart Plus 100 mg+25 mg (Tablet) - acme-laboratories-ltd
- Losatan HZ 50 mg+12.5 mg (Tablet) - popular-pharmaceuticals-ltd
- Losium Plus 50 mg+12.5 mg (Tablet) - ibn-sina-pharmaceuticals-ltd